Mirabella Financial Services LLP Sells 14,028 Shares of Synopsys, Inc. $SNPS

Mirabella Financial Services LLP cut its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 85.1% in the second quarter, HoldingsChannel reports. The firm owned 2,457 shares of the semiconductor company’s stock after selling 14,028 shares during the period. Mirabella Financial Services LLP’s holdings in Synopsys were worth $1,265,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. raised its holdings in shares of Synopsys by 1.6% in the second quarter. Vanguard Group Inc. now owns 15,060,784 shares of the semiconductor company’s stock valued at $7,721,363,000 after acquiring an additional 231,014 shares in the last quarter. Geode Capital Management LLC increased its position in Synopsys by 1.5% during the 2nd quarter. Geode Capital Management LLC now owns 3,545,892 shares of the semiconductor company’s stock valued at $1,810,214,000 after purchasing an additional 51,043 shares during the period. Ameriprise Financial Inc. raised its holdings in shares of Synopsys by 6.6% in the 1st quarter. Ameriprise Financial Inc. now owns 2,013,380 shares of the semiconductor company’s stock valued at $863,500,000 after purchasing an additional 125,199 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Synopsys by 20.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company’s stock valued at $778,928,000 after purchasing an additional 305,489 shares in the last quarter. Finally, Alliancebernstein L.P. lifted its position in shares of Synopsys by 22.2% in the 1st quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock worth $739,857,000 after purchasing an additional 313,218 shares during the period. Institutional investors own 85.47% of the company’s stock.

Synopsys Price Performance

NASDAQ SNPS opened at $463.74 on Friday. The stock’s fifty day moving average price is $437.46 and its 200 day moving average price is $505.76. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.62 and a quick ratio of 1.51. The company has a market cap of $86.14 billion, a price-to-earnings ratio of 36.40, a PEG ratio of 5.35 and a beta of 1.16.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same period in the prior year, the company posted $3.43 earnings per share. The firm’s revenue for the quarter was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS and its Q4 2025 guidance at 2.760-2.80 EPS. As a group, equities research analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts recently commented on SNPS shares. Citigroup began coverage on shares of Synopsys in a research note on Monday, November 24th. They issued a “buy” rating and a $580.00 price objective for the company. Rosenblatt Securities reissued a “neutral” rating and issued a $605.00 price target (down from $650.00) on shares of Synopsys in a research report on Wednesday, September 10th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research report on Wednesday, October 8th. Stifel Nicolaus decreased their price target on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Finally, BNP Paribas started coverage on shares of Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price objective for the company. Ten analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $555.33.

Insider Buying and Selling at Synopsys

In other Synopsys news, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the completion of the transaction, the chief accounting officer owned 20,520 shares in the company, valued at approximately $10,278,468. This trade represents a 32.48% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Robert G. Painter purchased 350 shares of Synopsys stock in a transaction that occurred on Thursday, September 11th. The shares were bought at an average price of $425.44 per share, with a total value of $148,904.00. Following the completion of the transaction, the director owned 2,291 shares of the company’s stock, valued at $974,683.04. This represents a 18.03% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.62% of the stock is owned by corporate insiders.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.